Congressional disclosures
| Office | Representative (IN-6) |
|---|---|
| Disclosed events | 636 |
| Purchases, all years | 207 |
| Sales | 427 |
| Publicly available | Transaction date | Asset | Action | Owner | Reported amount |
|---|---|---|---|---|---|
| 2026-06-06 | 2026-05-20 | JP Morgan 3-Year Auto Callable Buffer Note INDU/NDX/RTY- May 2026 | purchase | not_indicated | $5,000,001 - $25,000,000 |
| 2026-06-06 | 2026-05-20 | Morgan Stanley 37-Month One-time Callable Note INDU/SPX - May 2026 | purchase | not_indicated | $1,000,001 - $5,000,000 |
| 2026-03-14 | 2026-02-09 | Brighthouse Buffered Annuity Russell 2000 Cap Rate [VA] | sale | not_indicated | $5,000,001 - $25,000,000 |
| 2026-03-14 | 2026-02-09 | Brighthouse Buffered Annuity S&P 500 Trigger Rate [VA] | sale | not_indicated | $5,000,001 - $25,000,000 |
| 2026-03-14 | 2026-02-17 | Prudential RILA - 10% Buffer 3-year Alliance Bernstein 500 Plus Index [VA] | purchase | not_indicated | $1,000,001 - $5,000,000 |
| 2026-03-14 | 2026-02-17 | Prudential RILA - 10% Buffer 3-year S&P 500 Index [VA] | purchase | not_indicated | $1,000,001 - $5,000,000 |
| 2026-03-14 | 2026-02-17 | Prudential RILA - 10% Buffer 6-year Alliance Bernstein 500 Plus Index with participation rate [VA] | purchase | not_indicated | $1,000,001 - $5,000,000 |
| 2026-01-02 | 2025-12-30 | JP Morgan 3-year auto callable buffer note | purchase | not_indicated | $5,000,001 - $25,000,000 |
| 2026-01-02 | 2025-12-30 | JP Morgan 3-year one-time callable barrier note | purchase | not_indicated | $5,000,001 - $25,000,000 |
| 2026-01-01 | 2025-12-30 | JP Morgan 3-year auto callable buffer note | purchase | not_indicated | $5,000,001 - $25,000,000 |
| 2026-01-01 | 2025-12-29 | Prudential RILA - 10% Buffer 3-year Alliance Bernstein 500 Plus Index | purchase | not_indicated | $5,000,001 - $25,000,000 |
| 2025-12-31 | 2025-12-30 | JP Morgan 3-year auto callable buffer note | purchase | not_indicated | $5,000,001 - $25,000,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.